Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Onconova Therapeutics Inc - SIC # 2834 - PHARMACEUTICAL PREPARATIONS
Ticker
Exchange
SIC #
Website
Latest Ticker
ONTX
Nasdaq
2834
https://www.onconova.com/
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Onconova Therapeutics Inc
We Think Onconova Therapeutics (NASDAQ:ONTX) Needs To Drive Business Growth Carefully
- Mar 9th, 2024 1:28 pm
Onconova Therapeutics’ Rigosertib Poster Selected for AACR 2024
- Mar 8th, 2024 1:00 pm
Onconova Therapeutics’ Narazaciclib ASH Poster Highlights Activity in Treatment Resistant Mantle Cell Lymphoma
- Dec 12th, 2023 1:00 pm
Onconova Therapeutics’ Preclinical Narazaciclib Data at SABCS Highlights Differentiated Anti-Tumor Activity v. Other CDK4/6i’s
- Dec 8th, 2023 9:05 pm
Onconova Therapeutics to Present at NobleCon19, Noble Capital Markets’ Nineteenth Annual Emerging Growth Equity Conference
- Nov 28th, 2023 1:00 pm
Onconova Therapeutics, Inc. (NASDAQ:ONTX) Q3 2023 Earnings Call Transcript
- Nov 16th, 2023 1:44 pm
Onconova Therapeutics Reports Corporate Update and Announces Third Quarter 2023 Financial Results
- Nov 14th, 2023 9:05 pm
Onconova Therapeutics to Provide Corporate Update and Announce Third Quarter 2023 Financial Results on November 14, 2023
- Nov 7th, 2023 9:05 pm
Onconova Therapeutics’ ASH Poster To Focus on Narazaciclib in MCL
- Nov 2nd, 2023 2:37 pm
Onconova Expands Leadership Team with Two Key Appointments
- Oct 24th, 2023 12:00 pm
Promising Preclinical Narazaciclib Data Presented at MCL Meeting
- Oct 19th, 2023 12:00 pm
Encouraging Rigosertib Data Presented at EADV as Late Breaker
- Oct 12th, 2023 12:00 pm
Onconova Therapeutics to Present a Late-Breaking Abstract on Rigosertib at the 2023 EADV Congress
- Sep 28th, 2023 12:00 pm
Onconova Therapeutics to Participate at the H.C. Wainwright 25th Annual Global Investment Conference
- Sep 6th, 2023 12:00 pm
Onconova Therapeutics, Inc. (NASDAQ:ONTX) Q2 2023 Earnings Call Transcript
- Aug 13th, 2023 9:36 am
Q2 2023 Onconova Therapeutics Inc Earnings Call
- Aug 11th, 2023 11:57 am
Onconova Therapeutics Reports Corporate Update and Announces Second Quarter 2023 Financial Results
- Aug 10th, 2023 8:05 pm
Onconova Therapeutics to Provide Corporate Update and Announce Second Quarter 2023 Financial Results on August 10, 2023
- Aug 3rd, 2023 8:05 pm
Here's Why We're Watching Onconova Therapeutics' (NASDAQ:ONTX) Cash Burn Situation
- Jul 17th, 2023 10:59 am
Onconova Therapeutics Presents Preclinical Data on Narazaciclib at the 17th International Conference on Malignant Lymphoma
- Jun 14th, 2023 12:00 pm
Scroll